Varenicline increases striatal dopamine D2/3 receptor binding in rats

被引:20
|
作者
Crunelle, Cleo L. [1 ,2 ,3 ]
Miller, Michelle L. [1 ,2 ,3 ]
de Bruin, Kora [3 ]
van den Brink, Wim [1 ,2 ]
Booij, Jan [3 ]
机构
[1] Univ Amsterdam, Amsterdam Inst Addict Res, Acad Med Ctr, NL-1070 AW Amsterdam, Netherlands
[2] Univ Amsterdam, Dept Psychiat, Acad Med Ctr, NL-1070 AW Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Nucl Med, Acad Med Ctr, NL-1070 AW Amsterdam, Netherlands
关键词
123I-IB2M storage phosphor imaging; dopamine receptor; drug partial agonism; nicotric receptor alpha 4 beta 2; striatum; varenicline;
D O I
10.1111/j.1369-1600.2009.00168.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing dopamine D-2/3 receptor availability is postulated to be a treatment for drug addiction. Varenicline, an alpha 4 beta 2-nicotinic partial agonist, is effective for nicotine dependence. We hypothesize that varenicline increases dopamine D-2/3 receptor availability. Twenty male drug-naive rats were randomized to varenicline (2 mg/kg) or placebo for 14 days, and then injected with the dopamine D-2/3 radiotracer I-123-IBZM. We found significantly higher striatum-to-cerebellum binding ratios in both dorsal and ventral striatum for the varenicline group compared with placebo. Varenicline increases dopamine D-2/3 receptor availability in drug-naive rats. Therefore, varenicline may be an effective treatment for addictions other than smoking.
引用
收藏
页码:500 / 502
页数:3
相关论文
共 50 条
  • [1] VARENICLINE INCREASES STRIATAL DOPAMINE D2/3 RECEPTOR BINDING IN DRUG-NAIVE RATS
    Crunelle, C. L.
    Miller, M.
    Booij, J.
    van den Brink, W.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 : A34 - A34
  • [2] μ-Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man
    Hagelberg, N
    Kajander, JK
    Någren, K
    Hinkka, S
    Hietala, J
    Scheinin, H
    [J]. SYNAPSE, 2002, 45 (01) : 25 - 30
  • [3] Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats
    Crunelle, Cleo L.
    de Wit, Tim C.
    de Bruin, Kora
    Ramakers, Ruud M.
    van der Have, Frans
    Beekman, Freek J.
    van den Brink, Wim
    Booij, Jan
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (05) : 640 - 644
  • [4] The cannabinoid-1 receptor antagonist rimonabant increases striatal dopamine D2/3 receptor availability in rats
    van de Giessen, E.
    Crunelle, C.
    Schulz, S.
    Vanderschuren, L.
    de Bruin, K.
    van den Brink, W.
    Booij, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S12 - S13
  • [5] Effects of varenicline on dopamine D2/3 receptor binding in rats using ex vivo phosphor storage imaging
    Crunelle, C. L.
    Miller, M. L.
    De Bruin, K.
    Van den Brink, W.
    Booij, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S187 - S187
  • [6] Effects of varenicline on dopamine D2/3 receptor binding in rats using ex vivo phosphor storage imaging
    Crunelle, C. L.
    Miller, M. L.
    de Bruin, K.
    van den Brink, W.
    Booij, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S81 - S82
  • [7] μ-Receptor agonism with alfentanil increases striatal D2 receptor dopamine binding in man.: A PET study
    Hagelberg, NM
    Kajander, JK
    Hietala, J
    Nagren, K
    Scheinin, H
    [J]. ANESTHESIOLOGY, 2000, 93 (3A) : U131 - U131
  • [8] Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain
    N D Volkow
    G-J Wang
    J Logan
    D Alexoff
    J S Fowler
    P K Thanos
    C Wong
    V Casado
    S Ferre
    D Tomasi
    [J]. Translational Psychiatry, 2015, 5 : e549 - e549
  • [9] Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain
    Volkow, N. D.
    Wang, G-J
    Logan, J.
    Alexoff, D.
    Fowler, J. S.
    Thanos, P. K.
    Wong, C.
    Casado, V.
    Ferre, S.
    Tomasi, D.
    [J]. TRANSLATIONAL PSYCHIATRY, 2015, 5 : e549 - e549
  • [10] Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats
    Crunelle, Cleo L.
    Schulz, Sybille
    de Bruin, Kora
    Miller, Michelle L.
    van den Brink, Wim
    Booij, Jan
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 (02) : 205 - 210